Literature DB >> 17699753

Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells.

Wolfgang Breitwieser1, Steve Lyons, Ann Marie Flenniken, Garry Ashton, Gail Bruder, Mark Willington, Georges Lacaud, Valerie Kouskoff, Nic Jones.   

Abstract

The ATF2 transcription factor is phosphorylated by the stress-activated mitogen-activated protein kinases (MAPKs) JNK and p38. We show that this phosphorylation is essential for ATF2 function in vivo, since a mouse carrying mutations in the critical phosphorylation sites has a strong phenotype identical to that seen upon deletion of the DNA-binding domain. In addition, combining this mutant with a knockout of the ATF2 homolog, ATF7, results in embryonic lethality with severe abnormalities in the developing liver and heart. The mutant fetal liver is characterized by high levels of apoptosis in developing hepatocytes and haematopoietic cells. Furthermore, we observe a significant increase in active p38 due to loss of a negative feedback loop involving the ATF2-dependent transcriptional activation of MAPK phosphatases. In embryonic liver cells, this increase drives apoptosis, since it can be suppressed by chemical inhibition of p38. Our findings demonstrate the importance of finely regulating the activities of MAPKs during development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699753      PMCID: PMC1948861          DOI: 10.1101/gad.430207

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  45 in total

1.  Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells.

Authors:  R Paumelle; D Tulasne; C Leroy; J Coll; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

2.  Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development.

Authors:  R H Adams; A Porras; G Alonso; M Jones; K Vintersten; S Panelli; A Valladares; L Perez; R Klein; A R Nebreda
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

Review 3.  Classification of human B-ZIP proteins based on dimerization properties.

Authors:  Charles Vinson; Max Myakishev; Asha Acharya; Alain A Mir; Jonathan R Moll; Maria Bonovich
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

4.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

5.  Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice.

Authors:  A M Reimold; J Kim; R Finberg; L H Glimcher
Journal:  Int Immunol       Date:  2001-02       Impact factor: 4.823

6.  Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT).

Authors:  A Behrens; K Sabapathy; I Graef; M Cleary; G R Crabtree; E F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

Authors:  D Rudolph; W C Yeh; A Wakeham; B Rudolph; D Nallainathan; J Potter; A J Elia; T W Mak
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

8.  Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors.

Authors:  Tim C P Somervaille; David C Linch; Asim Khwaja
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

9.  p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway.

Authors:  Lijian Hui; Latifa Bakiri; Andreas Mairhorfer; Norbert Schweifer; Christian Haslinger; Lukas Kenner; Vukoslav Komnenovic; Harald Scheuch; Hartmut Beug; Erwin F Wagner
Journal:  Nat Genet       Date:  2007-04-29       Impact factor: 38.330

10.  Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.

Authors:  D Margriet Ouwens; Nancy D de Ruiter; Gerard C M van der Zon; Andrew P Carter; Jan Schouten; Corina van der Burgt; Klaas Kooistra; Johannes L Bos; J Antonie Maassen; Hans van Dam
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

View more
  56 in total

1.  Keep the 'phospho' on MAPK, be happy.

Authors:  Schahram Akbarian; Roger J Davis
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

2.  Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis.

Authors:  Tian-Fang Li; Lin Gao; Tzong-Jen Sheu; Erik R Sampson; Lisa M Flick; Yrjö T Konttinen; Di Chen; Edward M Schwarz; Michael J Zuscik; Jennifer H Jonason; Regis J O'Keefe
Journal:  Arthritis Rheum       Date:  2010-08

3.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning.

Authors:  John C Dreixler; Anthony Bratton; Eugenie Du; Afzhal R Shaikh; Brian Savoie; Michael Alexander; Marcus M Marcet; Steven Roth
Journal:  Exp Eye Res       Date:  2010-11-20       Impact factor: 3.467

Review 4.  Role of dual specificity phosphatases in biological responses to glucocorticoids.

Authors:  Andrew R Clark; Joana R S Martins; Carmen R Tchen
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

Review 5.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.

Authors:  Gregory Watson; Ze'ev A Ronai; Eric Lau
Journal:  Pharmacol Res       Date:  2017-02-15       Impact factor: 7.658

Review 6.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

7.  Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription.

Authors:  Takahito Yamasaki; Akinori Takahashi; Jianzhi Pan; Naoto Yamaguchi; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

8.  Epitope-guided engineering of monobody binders for in vivo inhibition of Erk-2 signaling.

Authors:  Jasdeep K Mann; Jordan F Wood; Anne Fleur Stephan; Emmanuel S Tzanakakis; Denise M Ferkey; Sheldon Park
Journal:  ACS Chem Biol       Date:  2012-12-18       Impact factor: 5.100

9.  The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development.

Authors:  Laurent Beck; Christine Leroy; Sarah Beck-Cormier; Anne Forand; Christine Salaün; Nadine Paris; Adeline Bernier; Pablo Ureña-Torres; Dominique Prié; Mario Ollero; Laure Coulombel; Gérard Friedlander
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

10.  Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation.

Authors:  Christopher J Staples; David M Owens; Jana V Maier; Andrew C B Cato; Stephen M Keyse
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.